Molecular MRI of atherosclerotic plaque with targeted contrast agents

Current Cardiovascular Imaging Reports

Volumn 2, Issue 2, 2009, Pages 87-94

  Sosnovik, David E ^a   Caravan, Peter ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79751490985     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-009-0012-y     Document Type: Review

References (44)

1. Sosnovik DE, Nahrendorf M, Weissleder R: Molecular magnetic resonance imaging in cardiovascular medicine. Circulation 2007, 115: 2076-2086.
2. Jaffer FA, Libby P, Weissleder R: Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 2006, 47: 1328-1338.
3. Nahrendorf M, Jaffer FA, Kelly KA, et al.: Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114: 1504-1511.
4. Briley-Saebo KC, Shaw PX, Mulder WJ, et al.: Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation 2008, 117: 3206-3215.
5. Korosoglou G, Weiss RG, Kedziorek DA, et al.: Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol 2008, 52: 483-491.
6. Winter PM, Morawski AM, Caruthers SD, et al.: Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003, 108: 2270-2274.
7. Botnar RM, Perez AS, Witte S, et al.: In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004, 109: 2023-2029.
8. Trivedi RA, U-King-Im JM, Graves MJ, et al.: In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004, 35: 1631-1635.
9. Kooi ME, Cappendijk VC, Cleutjens KB, et al.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107: 2453-2458.
10. Spuentrup E, Botnar RM, Wiethoff AJ, et al.: MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 2008, 18: 1995-2005.
11. Flacke S, Fischer S, Scott MJ, et al.: Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001, 104: 1280-1285.
12. Overoye-Chan K, Koerner S, Looby RJ, et al.: EP-2104R: a fibrin-specific gadolinium-based MRI contrast agent for detection of thrombus. J Am Chem Soc 2008, 130: 6025-6039.
13. Chen JW, Pham W, Weissleder R, Bogdanov A Jr: Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med 2004, 52: 1021-1028.
14. Lancelot E, Amirbekian V, Brigger I, et al.: Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol 2008, 28: 425-432.
15. Lipinski MJ, Amirbekian V, Frias JC, et al.: MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med 2006, 56: 601-610.
16. Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al.: Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A 2007, 104: 961-966.
17. Mulder WJ, Strijkers GJ, Briley-Saboe KC, et al.: Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn Reson Med 2007, 58: 1164-1170.
18. Li H, Gray BD, Corbin I, et al.: MR and fl uorescent imaging of low-density lipoprotein receptors. Acad Radiol 2004, 11: 1251-1259.
19. Frias JC, Williams KJ, Fisher EA, Fayad ZA: Recombinant HDL-like nanoparticles: a specifi c contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 2004, 126: 16316-16317.
20. Meding J, Urich M, Licha K, et al.: Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofl uorine M. Contrast Media Mol Imaging 2007, 2: 120-129.
21. Barkhausen J, Ebert W, Heyer C, et al.: Detection of atherosclerotic plaque with Gadofl uorine-enhanced magnetic resonance imaging. Circulation 2003, 108: 605-609.
22. Yeon SB, Sabir A, Clouse M, et al.: Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. J Am Coll Cardiol 2007, 50: 441-447.
23. Fuster V, Moreno PR, Fayad ZA, et al.: Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005, 46: 937-954.
24. Shah PK: Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Prog Cardiovasc Dis 2002, 44: 357-368.
25. Virmani R, Burke AP, Kolodgie FD, Farb A: Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 2002, 15: 439-446.
26. Sirol M, Aguinaldo JG, Graham PB, et al.: Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis 2005, 182: 79-85.
27. Botnar RM, Buecker A, Wiethoff AJ, et al.: In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004, 110: 1463-1466.
28. Spuentrup E, Buecker A, Katoh M, et al.: Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005, 111: 1377-1382.
29. Spuentrup E, Fausten B, Kinzel S, et al.: Molecular magnetic resonance imaging of atrial clots in a swine model. Circulation 2005, 112: 396-399.
30. Spuentrup E, Katoh M, Wiethoff AJ, et al.: Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. Am J Respir Crit Care Med 2005, 172: 494-500.
31. Spuentrup E, Katoh M, Buecker A, et al.: Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent. Invest Radiol 2007, 42: 586-595.
32. Sosnovik DE, Nahrendorf M, Weissleder R: Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol 2008, 103: 122-130.
33. McAteer MA, Schneider JE, Ali ZA, et al.: Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 2008, 28: 77-83.
34. von zur Muhlen C, von Elverfeldt D, Moeller JA, et al.: Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008, 118: 258-267.
35. Jaffer FA, Nahrendorf M, Sosnovik D, et al.: Cellular imaging of inflammation in atherosclerosis using magneto-fluorescent nanomaterials. Mol Imaging 2006, 5: 85-92.
36. Weissleder R, Kelly K, Sun EY, et al.: Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005, 23: 1418-1423.
37. Sosnovik DE, Nahrendorf M, Deliolanis N, et al.: Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation 2007, 115: 1384-1391.
38. Sosnovik DE, Schellenberger EA, Nahrendorf M, et al.: Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 2005, 54: 718-724.
39. Stuber M, Gilson WD, Schar M, et al.: Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007, 58: 1072-1077.
40. Farrar CT, Dai G, Novikov M, et al.: Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed 2008, 21: 453-463.
41. Mani V, Briley-Saebo KC, Hyafil F, Fayad ZA: Feasibility of in vivo identification of endogenous ferritin with positive contrast MRI in rabbit carotid crush injury using GRASP. Magn Reson Med 2006, 56: 1096-1106.
42. Harisinghani MG, Barentsz J, Hahn PF, et al.: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003, 348: 2491-2499.
43. Winter PM, Neubauer AM, Caruthers SD, et al.: Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26: 2103-2109.
44. Nahrendorf M, Zhang H, Hembrador S, et al.: Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008, 117: 379-387.